Onesource Specialty Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2025
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OneSource Specialty Pharma Limited has called its 18th Annual General Meeting for September 22, 2025, at 5:00 PM IST via video conferencing — this is the company's first AGM since listing on NSE and BSE on January 24, 2025. Key items on the agenda include adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, and re-appointment of Arun Kumar (founder of Strides Pharma) as Non-Executive Director, who retires by rotation. Shareholders will also vote to approve material related party transactions with Strides Pharma Science Limited (capped at ₹4,000 million / ~USD 47.1 million, about 28% of FY25 consolidated turnover of ₹14,448.53 million) and with Strides Pharma Inc, USA (capped at ₹5,200 million / ~USD 61.2 million, about 36% of consolidated turnover). Additionally, the meeting seeks approval for appointing M/s. DV & Associates as Secretarial Auditors for five years, and remuneration of ₹1.2 million to the Cost Auditor for FY26. Arun Kumar, being a common promoter, will abstain from voting on the related party resolutions.
Approval of these large related party transactions is crucial as OneSource continues to rely on Strides group entities (promoter-related) for US front-end operations and soft gelatin manufacturing access post the 2024 demerger scheme. Shareholders should note the concentrated nature of these dealings and the voting restriction on the interested promoter, which may make approval easier to secure.